PNC Financial Services Group’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
PNC Financial Services Group's STIM Position: Q3 2026 in Review
PNC Financial Services Group reduced its Neuronetics (STIM) stake by 24% in Q3 2026, selling an estimated $74 and leaving 94 shares worth $220. The position accounts for ﹤0.01% of the portfolio, ranked #5225.
PNC Financial Services Group first reported a position in STIM in Q2 2020 and has held it in 14 quarters since. The position peaked at $16K in Q2 2021. 96 funds tracked by Wall St. Rank hold STIM as of Q3 2026.
- PNC Financial Services Group held 94 shares of Neuronetics worth $220 as of Q3 2026.
- PNC Financial Services Group sold 30 Neuronetics shares in Q3 2026, an estimated $74.
- Neuronetics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #5225 holding.
- PNC Financial Services Group first reported a position in Neuronetics in Q2 2020 and has held it in 14 quarters since.
- PNC Financial Services Group's Neuronetics position peaked at $16K in Q2 2021.
- 96 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.